Table 2.

Patient demographics, current users of T therapy

	N = 407
Menopausal status, N (percent)
Premenopausal	43 (10.6%)
Postmenopausal	364 (89.4%)
Age, mean (SD), (range)
1st insert	51.7 + 8.1 y (27.4–80.0)
Current	61.1 + 8.4 y (37.9–91.7)
Weight, mean (SD)
1st insert	69.6 + 15.1 kg
Current	69.8 + 13.6 kg
Length of T therapy, mean (SD)	9.34 + 1.71 y
Current T dose, mean (SD)	192 + 50 mg
Aromatase inhibitor use, N (percent)
Total	86 (21.1%)
Premenopausal	27 (62.8%)
Postmenopausal	59 (16.2%)